Published in AIDS Weekly, November 22nd, 1999
Michael Andang and colleagues from the Karolinska Institute, Sweden, and the University of California, USA, used HIV-1 pseudotype virus to infect mouse primary spleen cells ex vivo with the purpose of studying anti-HIV-1 hairpin ribozyme efficacy in a transgenic mouse model. The results of their study were published in the Proceedings of the National Academy of Sciences ("Dose-Response Resistance to HIV-1/MuLV Pseudotype Virus ex vivo in a Hairpin Ribozyme Transgenic Mouse Model," PNAS, October 26, 1999;96(22):12749-53).
"There is a need for a rapid and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.